Medtronic
MDT
1,409 hedge funds and large institutions have $94B invested in Medtronic in 2018 Q2 according to their latest regulatory filings, with 109 funds opening new positions, 549 increasing their positions, 574 reducing their positions, and 70 closing their positions.
56% more first-time investments, than exits
New positions opened: 109 | Existing positions closed: 70
48% more call options, than puts
Call options by funds: $796M | Put options by funds: $540M
23% more funds holding in top 10
Funds holding in top 10: 40 → 49 (+9)
6% more capital invested
Capital invested by funds: $88.7B → $94B (+$5.3B)
2% more funds holding
Funds holding: 1,381 → 1,409 (+28)
0.25% less ownership
Funds ownership: 81.59% → 81.34% (-0.25%)
4% less repeat investments, than reductions
Existing positions increased: 549 | Existing positions reduced: 574
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$488M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$205M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$179M |
| 4 |
BlackRock
New York
|
+$164M |
| 5 |
Bank of New York Mellon
New York
|
+$134M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$288M |
| 2 |
Goldman Sachs
New York
|
-$276M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$208M |
| 4 |
D.E. Shaw & Co
New York
|
-$170M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$137M |
MDT Hedge Fund Activity: Q2 2018 in Review
1,409 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q2 2018, worth a combined $94B — up 6% from $88.7B a quarter earlier.
Buyers outnumbered sellers: 109 funds opened new MDT positions and 70 closed out — a net gain of 39 holders — while 549 added to existing stakes and 574 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $488M. The largest seller was Capital Research Global Investors, cutting an estimated $288M.
- 1,409 institutional investors held Medtronic (MDT) as of Q2 2018, up from 1,381 in Q1 2018.
- Funds reported $94B of Medtronic stock for Q2 2018, up 6% quarter-over-quarter.
- 109 funds opened new Medtronic positions in Q2 2018 and 70 closed out, a net change of +39 holders.
- The largest Medtronic buyer in Q2 2018 was JP Morgan Chase, an estimated $488M added.
- The largest Medtronic seller in Q2 2018 was Capital Research Global Investors, an estimated $288M sold.
Based on aggregated 13F filings for Q2 2018.